IPCA Laboratories LTD

Ipca Laboratories Ltd (IPCALAB) is a mid-cap Healthcare company valued at ₹46,494 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Ipca Laboratories Ltd last traded at ₹1,908, modestly down 0.19% on the day.

Recent developments

On 2026-08-07, the company announced a dividend of ₹6.00 per share, with the ex-date set for that day. Foreign institutional holding increased by 0.10 points in the quarter, while domestic institutional holding fell by 0.08 points.

Financial performance

The company's business is improving, with annual revenue rising 8.4% and annual net profit jumping 50.8%. The latest quarter saw revenue grow 20.7% and net profit surge 82.1% compared to the same quarter a year earlier. Net profit margin widened 3.4 percentage points to 12.3%, while return on equity remained steady at 14.2%.

Valuation multiples

The stock trades at 42.4 times earnings, a premium to the Healthcare median of 32.0, 6.20 times book value. It yields 0.3%.

Things to watch

The stock is 6.0% below its 52-week high. Promoter holding remained at 44.72%, but domestic institutional holding decreased by 0.08 points in the quarter. Debt to equity is low at 0.10, but profit growth slowed in the past five years with a 0.7% annual increase.

Where it stands

The company's latest quarter net profit rose 82.1% compared to the same quarter a year earlier, while annual net profit grew 50.8%. The stock is 6.0% below its 52-week high.

Summarised by DocStoX's model on 2026-10-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.